Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

BioBoss

BioBoss artwork

Welcome to Season 2 of BioBoss

Dec 31, 20191 minAudio
ShareXLinkedInFacebookWhatsAppEmail

BioBoss host John Simboli welcomes you to Season 2!

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show. Tap a time to play from there.

John SimboliThanks, BioBoss subscribers around the world for making Season 1 of the podcast a success. And thanks to the biopharma founders and CEOs whose insights are the foundation of BioBoss. When I launched BioBoss in January, 2019 my goal was to give subscribers a seat at the table—an opportunity to listen in on my conversations with biopharma leaders, to hear firsthand how they wrestle with the challenge of creating clarity out of ambiguity.

John SimboliIn 2020 I invite BioBoss listeners to experience Season 2 of conversations with a new group of founders and CEOs. I'll also return to speak with some of my Season 1 guests to hear more from these leaders and the advances at their companies. Welcome to Season 2! I'm John Simboli. You're listening to BioBoss.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Stephan Jackman: CEO of Alzamend Neuro

    Oct 29, 202623 minAudio

    Stephan Jackman, CEO of Alzamend Neuro, shares his insights about leadership in biopharma and how Alzamend is working to develop effective treatments for psychiatric disorders.

    Credit the people on this episode

  2. Ryan Beal: Co-Founder and CEO of Dyve Biosciences

    Sep 22, 202638 minAudio

    Ryan Beal, CEO of Dyve Biosciences, shares his insights about leadership in biopharma and how Dyve is working to deliver targeted pH modulation to treat a range of immunologic and oncologic diseases.

    Credit the people on this episode

  3. Haseeb Ahmad - CEO of Purespring Therapeutics

    Aug 25, 202642 minAudio

    Haseeb Ahmad, CEO of Purespring Therapeutics, shares his insights about leadership in biopharma and how Purespring is working to help patients with kidney diseases to live fuller, healthier lives.

    Credit the people on this episode

  4. Lance Baldo: CEO of Beacon Therapeutics

    Jul 29, 202626 minAudio

    Lance Baldo, CEO of Beacon Therapeutics, shares his insights about leadership in biopharma and how Beacon is working to save and restore sight for people living with rare and prevalent ocular diseases.

    Credit the people on this episode

  5. Shaun Bagai: CEO of RenovoRX

    Jun 25, 202634 minAudio

    Shaun Bagai, CEO of RenovoRX, shares his insights about leadership in biopharma and how RenovoRX is working to develop targeted oncology therapies and commercialize its FDA cleared drug delivery device.

    Credit the people on this episode